NFKB1 and hepatocellular carcinoma: Li et al (88) evaluated the apoptotic activity of paeonol in hepatocellular carcinoma and reported that the drug decreased NF-κB p65/50 and protein apoptosis inhibitor-5 in the promotion of apoptosis and suppressed NF-κB signaling pathway.